7-hydroxymitragynine, or 7OH, is a concentrated compound derived from the kratom plant that acts like a powerful opioid at the brain’s mu-receptors. It is roughly 10 times more potent than morphine and sold in many states at gas stations, smoke shops, and online in gummies, pills, and drink mixes [1].
7-OH carries a very real risk of dependence, overdose, and withdrawal that mirrors typical opioid withdrawal, making supervised detox an important part of recovery.
Is 7OH the Same Thing as Kratom?
No, but the connection is real and the distinction matters. Kratom is a plant native to Southeast Asia. Its primary active compound is mitragynine, a partial mu-opioid agonist [2]. For years, people have used kratom leaf tea and powder to manage pain, ease anxiety, or self-treat opioid withdrawal. It has risks, but at traditional doses, its opioid activity is relatively mild.
7-hydroxymitragynine (7OH) is a different story. It is naturally occurring only in trace amounts in kratom leaves. The 7OH products currently flooding the market are not kratom leaves. They are concentrated, semisynthetic extracts engineered to push that minor compound to the center of the product [2].
Why Is 7OH So Much Stronger Than Kratom?
Mitragynine, the primary kratom alkaloid, has approximately 25% of morphine’s potency at mu-opioid receptors. 7-hydroxymitragynine has approximately 10 times morphine’s potency at those same receptors [1]. 7OH also acts at alpha-2, kappa, and delta opioid receptors, widening its physical impact.
Because it is sold in unregulated consumer products with no consistent dosing standards, users rarely know how much they are actually taking. A gummy or drink sold at a gas station counter carries no guaranteed potency label, and the dose in one product may be dramatically different from another with the same branding.
Where Is 7OH Sold and Who Is Using It?
Due to the recent boom in 7OH and little regulations nationwide, 7OH has become particularly difficult for clinicians and treatment programs to track. It is not sold in dispensaries or pharmacies. It is available over the counter at gas stations, smoke shops, vape shops, and online retailers, often marketed as a supplement or botanical product, and comes in the form of gummies, capsules, drink powders, and pre-mixed shots.
The labeling frequently uses terms like “enhanced kratom,” “kratom extract,” or “mitragynine concentrate,” which can mislead users who associate kratom with the relatively milder leaf product. Many people begin using 7OH without understanding that it functions as a potent synthetic opioid.
Patients presenting to treatment programs frequently do not disclose 7OH use because they do not consider it a “drug.” Our admissions team is increasingly hearing from callers who describe themselves as kratom users but are actually using 7OH products.
What Are the Risks of 7OH Use?
Dependence develops quickly. At high concentrations, 7OH activates opioid receptors and creates a physiological dependence pattern that mirrors prescription opioid use disorder. Users who attempt to stop often find they cannot do so without significant physical distress.
Overdose is a real risk. 7OH can cause respiratory depression comparable to or exceeding that of morphine-class opioids. Mixed into drinks with unmarked dosing, it creates unpredictable exposure. Naloxone (Narcan) should be administered for suspected 7OH overdose, as the drug’s opioid receptor activity makes it naloxone-reversible [1].
Withdrawal is intense. Symptoms of 7OH withdrawal include muscle aches, gastrointestinal distress, anxiety, insomnia, and dysphoria. Buprenorphine-naloxone has been supported by multiple case reports as an effective management strategy [1].
How Should Treatment Programs Respond to 7OH?
Intake and admissions staff should add 7OH and “enhanced kratom” to standard substance use screening language. Patients will not always volunteer this information, either because they do not consider it a drug, are unaware of what they are taking, or are embarrassed, but asking directly matters.
Clinical staff typically treat 7OH withdrawal as opioid withdrawal. They assess symptoms with the Clinical Opiate Withdrawal Scale (COWS), a standard checklist clinicians use to score withdrawal severity based on signs like heart rate, sweating, restlessness, and muscle aches. From there, care can include buprenorphine-based medication-assisted treatment (MAT) and ongoing recovery support through therapy, skill building, and holistic wellness activities. Do not assume a lighter approach is appropriate because the product came from a gas station.
If you are not sure whether someone’s current use of kratom products has shifted toward 7OH, ask them directly about the form: leaf powder, capsules, drinks, gummies, or extracts. The product form often indicates the compound.
Detox Safely from Kratom and 7OH in Michigan
If you or someone you love has been using 7OH products and things are harder to stop than you expected, that is not a willpower problem. That is opioid dependence, and it is treatable.
Rushton Recovery offers medically supervised detox and evidence-based treatment for substance use, including dependency on kratom-derived opioid compounds. Our team understands this space is new and confusing—we will meet you where you are and guide you through the process from admissions to recovery.
Sources
[1] Indian Health Service. (2026, June 1). Health alert: Kratom & 7-hydroxymitragynine (7-OH). Northwest Portland Area Indian Health Board. https://indiancountryecho.npaihb.org/wp-content/uploads/2026/06/Health-Alert-KRATOM-7-HYDROXYMITRAGYNINE-7-OH_Final.pdf
[2] New York State Department of Health. (2025, December). Kratom: What clinicians need to know. https://health.ny.gov/community/drug_use/kratom/clinicians.html